clinical trial · NCT05887843
Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis
Sandoz·phase1·terminated·n = 38
Seasonal Allergic RhinitisMometasone + AzelastineMometasone FuroateAzelastine Hydrochloride
brief summary
This study will compare the PK parameters of the combination test formulation to monotherapy reference products (mometasone furoate and azelastine hydrochloride) in adolescents and young adult patients with seasonal allergic rhinitis.
started
Jun 8, 2023
primary completion
Sep 8, 2023
completion
Sep 8, 2023
last updated
Sep 28, 2023
official title
An Open-label, Single-Dose, Three-way Crossover Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents (12 to 17 Years of Age) and Young Adults (18 to 24 Years of Age) With Seasonal Allergic Rhinitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol